Medicare Enrolled
Dr. Dana Point, MD
Urology Physician · Southport, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Point from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Point?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Point
Dr. Dana Point is an urology physician in Southport, NC, with 15 years of NPI registration. Based on federal Medicare data, Dr. Point performed 10,403 Medicare services across 3,881 unique beneficiaries.
Between the years covered by Open Payments, Dr. Point received a total of $5,624 from 48 pharmaceutical and/or device companies across 266 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Point is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 4% volume in NC
$5,624 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,403
Medicare services
Top 4% in NC for urology physician
3,881
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~694 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 3,477 | $2 | $8 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
1,287 | $3 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
839 | $90 | $200 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
803 | $0 | $3 |
| Leuprolide injectable, camcevi, 1 mg | 798 | $67 | $120 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
631 | $7 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
498 | $61 | $140 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
446 | $8 | $20 |
| PSA test (prostate cancer screening) | 435 | $18 | $100 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
162 | $174 | $431 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
138 | $116 | $275 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
115 | $22 | $113 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
81 | $66 | $262 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
73 | $25 | $130 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
67 | $19 | $73 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
49 | $131 | $300 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
48 | $11 | $30 |
| Imaging guidance for procedure, 60 minutes or less Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less. |
47 | $12 | $106 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $38 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
35 | $115 | $350 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
32 | $119 | $1,680 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
31 | $23 | $75 |
| New patient office visit, complex (60-74 min) | 29 | $170 | $350 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
24 | $43 | $305 |
| Injection, garamycin, gentamicin, up to 80 mg | 24 | $2 | $16 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
23 | $322 | $1,007 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
18 | $37 | $177 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
18 | $279 | $680 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
18 | $147 | $350 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
17 | $25 | $350 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
16 | $543 | $2,675 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
16 | $37 | $256 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
15 | $173 | $455 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
14 | $58 | $265 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
14 | $57 | $119 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $49 | $95 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
13 | $598 | $1,850 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.5% high complexity
16.4% medium
83.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,624
Total received (2019-2024)
Avg $1,125/year across 5 years
Top 28% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
266
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,455 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$169 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,753
2023
$1,638
2022
$1,393
2021
$742
2019
$97
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$254
Janssen Biotech, Inc.
$248
Sumitomo Pharma America, Inc.
$195
Astellas Pharma US Inc
$161
PFIZER INC.
$131
180 Medical, Inc.
$92
UROGEN PHARMA, INC.
$80
ABBVIE INC.
$78
AngioDynamics, Inc.
$63
PROCEPT BioRobotics Corporation
$59
COLOPLAST CORP
$44
Tolmar, Inc.
$43
Boston Scientific Corporation
$40
AstraZeneca Pharmaceuticals LP
$38
IMMUNITYBIO, INC.
$37
ACCORD HEALTHCARE, INC.
$36
Endo USA, Inc.
$27
Novartis Pharmaceuticals Corporation
$24
Merck Sharp & Dohme LLC
$19
PROGENICS PHARMACEUTICALS, INC.
$19
Calyxo, Inc.
$18
Smith+Nephew, Inc.
$17
Ferring Pharmaceuticals Inc.
$17
Antares Pharma, Inc.
$14
Top 3 companies account for 39.7% of 2024 payments
All-time payments by company (2019-2024) ›
Astellas Pharma US Inc
$867
Janssen Biotech, Inc.
$767
Dendreon Pharmaceuticals LLC
$716
Sumitomo Pharma America, Inc.
$472
PFIZER INC.
$337
Myriad Genetic Laboratories, Inc.
$216
180 Medical, Inc.
$203
Myovant Sciences Inc.
$176
Antares Pharma, Inc.
$170
UROVANT SCIENCES INC
$147
ACCORD HEALTHCARE, INC.
$117
AstraZeneca Pharmaceuticals LP
$113
ABBVIE INC.
$107
UROGEN PHARMA, INC.
$94
Novartis Pharmaceuticals Corporation
$83
Blue Earth Diagnostics Limited
$72
AngioDynamics, Inc.
$63
Merck Sharp & Dohme LLC
$61
COLOPLAST CORP
$60
PROCEPT BioRobotics Corporation
$59
Boston Scientific Corporation
$59
Smith+Nephew, Inc.
$51
Tolmar, Inc.
$43
Accord Healthcare, Inc.
$39
Olympus America Inc.
$39
Palette Life Sciences, Inc.
$38
IMMUNITYBIO, INC.
$37
KARL STORZ Endoscopy-America
$35
Photocure Inc
$32
Bayer HealthCare Pharmaceuticals Inc.
$29
Endo USA, Inc.
$27
Bayer Healthcare Pharmaceuticals Inc.
$26
Teleflex LLC
$25
ABC Home Medical Supply, Inc.
$24
Merck Sharp & Dohme Corporation
$22
Endo Pharmaceuticals Inc.
$21
Supernus Pharmaceuticals, Inc.
$21
TOLMAR Pharmaceuticals, Inc.
$19
PROGENICS PHARMACEUTICALS, INC.
$19
Calyxo, Inc.
$18
Ferring Pharmaceuticals Inc.
$17
Axonics, Inc.
$15
Hollister Incorporated
$15
Kowa Pharmaceuticals America, Inc.
$13
Acerus Pharmaceuticals Corporation
$12
Allergan Inc.
$12
SUN PHARMACEUTICAL INDUSTRIES INC.
$12
EDAP TECHNOMED INC
$7
Top 3 companies account for 41.8% of all-time payments
Associated products mentioned in payments ›
24FR BIPLR COAG ELECTRDE · ADSTILADRIN · ANKTIVA · AQUABEAM SYSTEM · Axonics · Axumin · BOTOX · BRAC CDx · BRACAnalysis CDx · CAMCEVI · CURE CATHETER · CVAC ASPIRATION SYSTEM · Cysview · ELIGARD · ERLEADA · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENTLECATH · GentleCath · Infyna Chic · JELMYTO · KEYTRUDA · LYNPARZA · LithoVue · Luja Coude · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Nubeqa · ORGOVYX · PKG/6 · PLUVICTO · POSLUMA · PROVENGE · PYLARIFY · Prolaris · SEGLENTIS · STERILE · STRAVIX · SpaceOAR VUE System - 10mL · SpeediCath · UROLIFT · Veozah · WAINUA · XIAFLEX · XTANDI · XYOSTED · Xtandi · YONSA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
19
Per 100K population
13.0
County median income
$74,034
Nearest hospital
J ARTHUR DOSHER MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Point is a clinical cardiology specialist, with above-average Medicare volume (top 4% in NC), with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Point experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Point performed 3,477 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Point receive payments from pharmaceutical companies?
Yes. Dr. Point received a total of $5,624 from 48 companies across 266 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Point's costs compare to other urology physicians in Southport?
Dr. Point's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Point) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Southport
Browse urology physicians in Southport ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NC
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NC
Which NC urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology